These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31792275)

  • 1. Benefits and barriers in the design of harmonized access agreements for international data sharing.
    Saulnier KM; Bujold D; Dyke SOM; Dupras C; Beck S; Bourque G; Joly Y
    Sci Data; 2019 Dec; 6(1):297. PubMed ID: 31792275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Access by Design, Benefits if Convenient: A Closer Look at the Pandemic Influenza Preparedness Framework's Standard Material Transfer Agreements.
    Rourke MF
    Milbank Q; 2019 Mar; 97(1):91-112. PubMed ID: 30637812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Innovative patient access schemes for the adoption of new technology: risk-sharing agreements].
    Espín J; Oliva J; Rodríguez-Barrios JM
    Gac Sanit; 2010; 24(6):491-7. PubMed ID: 21074292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk-sharing agreements, present and future.
    Gonçalves FR; Santos S; Silva C; Sousa G
    Ecancermedicalscience; 2018; 12():823. PubMed ID: 29743943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. User-focused data sharing agreements: a foundation for the genomic future.
    Petersen C
    JAMIA Open; 2019 Dec; 2(4):402-406. PubMed ID: 32025634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk sharing methods in middle income countries].
    Inotai A; Kaló Z
    Acta Pharm Hung; 2012; 82(1):43-52. PubMed ID: 22570986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing harmonized health data collection, sharing and linkage in Denmark and Switzerland: A systematic review.
    Geneviève LD; Martani A; Mallet MC; Wangmo T; Elger BS
    PLoS One; 2019; 14(12):e0226015. PubMed ID: 31830124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sharing the benefits of genetic resources: from biodiversity to human genetics.
    Schroeder D; Lasén-Díaz C
    Dev World Bioeth; 2006 Dec; 6(3):135-43. PubMed ID: 17038005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk sharing or risk shifting? On the development of patient access schemes in the process of updating the national list of health services in Israel.
    Triki N; Ash N; Porath A; Birnbaum Y; Greenberg D; Hammerman A
    Expert Rev Pharmacoecon Outcomes Res; 2019 Dec; 19(6):749-753. PubMed ID: 31825682
    [No Abstract]   [Full Text] [Related]  

  • 10. Performance-based risk-sharing arrangements-good practices for design, implementation, and evaluation: report of the ISPOR good practices for performance-based risk-sharing arrangements task force.
    Garrison LP; Towse A; Briggs A; de Pouvourville G; Grueger J; Mohr PE; Severens JL; Siviero P; Sleeper M
    Value Health; 2013; 16(5):703-19. PubMed ID: 23947963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The trends and constructive ambiguity in international agreements on intellectual property and pharmaceutical affairs: Implications for domestic legislations in low- and middle-income countries.
    Son KB; Lee TJ
    Glob Public Health; 2018 Sep; 13(9):1169-1178. PubMed ID: 28585477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genebank Operation in the Arena of Access and Benefit-Sharing Policies.
    Brink M; van Hintum T
    Front Plant Sci; 2019; 10():1712. PubMed ID: 32038684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of risk-sharing contracts as perceived by Spanish hospital pharmacists.
    Lorente R; Antonanzas F; Rodriguez-Ibeas R
    Health Econ Rev; 2019 Jul; 9(1):25. PubMed ID: 31317339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The simple economics of risk-sharing agreements between the NHS and the pharmaceutical industry.
    Barros PP
    Health Econ; 2011 Apr; 20(4):461-70. PubMed ID: 21394816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International social security agreements: the U.S. experience.
    Butcher P; Erdos J
    Soc Secur Bull; 1988 Sep; 51(9):4-12. PubMed ID: 3187855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Data Rights and Responsibilities: A Human Rights Perspective on Data Sharing.
    Harris TL; Wyndham JM
    J Empir Res Hum Res Ethics; 2015 Jul; 10(3):334-7. PubMed ID: 26297755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knowledge sharing in the health scenario.
    Lluch-Ariet M; Brugués de la Torre A; Vallverdú F; Pegueroles-Vallés J
    J Transl Med; 2014 Nov; 12 Suppl 2(Suppl 2):S8. PubMed ID: 25471452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The alcohol industry and trade agreements: a preliminary assessment.
    Zeigler DW
    Addiction; 2009 Feb; 104 Suppl 1():13-26. PubMed ID: 19133911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How ownership rights over microorganisms affect infectious disease control and innovation: A root-cause analysis of barriers to data sharing as experienced by key stakeholders.
    Ribeiro CDS; van Roode MY; Haringhuizen GB; Koopmans MP; Claassen E; van de Burgwal LHM
    PLoS One; 2018; 13(5):e0195885. PubMed ID: 29718947
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.